Basit öğe kaydını göster

dc.contributor.authorGurkan, H.
dc.contributor.authorAydın, Feyyaz Fatih
dc.contributor.authorNane, I.
dc.contributor.authorOguz, F. S.
dc.contributor.authorCaliskan, Y.
dc.contributor.authorKekik, C.
dc.contributor.authorTurkmen, A.
dc.contributor.authorAkgul, Sebahat
dc.date.accessioned2021-03-06T21:43:03Z
dc.date.available2021-03-06T21:43:03Z
dc.date.issued2012
dc.identifier.citationAkgul S., Oguz F. S. , Caliskan Y., Kekik C., Gurkan H., Turkmen A., Nane I., Aydın F. F. , "The Effect of Glutathion S-Transferase Polymoprhisms and Anti-GSST1 Antibodies on Allograft Functions in Recipients of Renal Transplant", TRANSPLANTATION PROCEEDINGS, cilt.44, ss.1679-1684, 2012
dc.identifier.issn0041-1345
dc.identifier.otherav_fff6a5ff-e4dc-4a37-9f0a-24bd0b5e6f5a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/167321
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2012.04.004
dc.description.abstractThe balance between oxidative stress and anti-oxidant defense systems after renal transplantation may explain the development and progression of allograft dysfunction. Glutathione S-transferase (GST) decreases the damage from oxidative stress. In contrast, recipient antibodies against GSTT1 expressed on the graft are believed to cause its dysfunction. The aim of our research was to study the probable relationship to rejection between GST gene polymorphisms and anti-GSTT1. antibodies. We included 122 patients transplantations from living donors and 51 healthy individuals as controls group in our study. The patient groups were comprised of 57 patients who did and 65 who did not experienced rejection episode. Polymerase chain reactions were used to detect GSTM1 and GSTT1 polymorphisms, whereas PCR-.RFLP (restriction fragment length polymorphism), for GSTP1 polymorphism. An enzyme-linked immunosorbent assay method was used for anti-GSTT1. antibody scans. There was no significant difference between the groups for allele and genotype frequencies of GSTT1, GSTM1, GSTP1. polymorphisms of the recipients, donors, and controls. Within the rejection group the frequency of patients with the GSTM1 null genotype was higher among subjects prescribed cyclosporine A versus tacrolimus (P = .029). Among the entire patient group, 46 subjects with GSTT1 null genotype were scanned for anti-GSTT1 antibody which was detected in 5 of 8 patients with an acute rejection episode (P = .04). Anti-GSTT1. antibody was observed more frequently albeit not significantly, among the cyclosporine versus tacrolimus patient group (P = .16). This study suggested that GSTM1 genotype may be important for cyclosporine detoxification and for allograft outcomes clue to drug nephrotoxicity. After transplantation, antigens distinct from the HLA system such as GSTT1 protein may also be targets for alloimmune responses.
dc.language.isoeng
dc.subjectTıp
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectCERRAHİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTRANSPLANTASYON
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleThe Effect of Glutathion S-Transferase Polymoprhisms and Anti-GSST1 Antibodies on Allograft Functions in Recipients of Renal Transplant
dc.typeMakale
dc.relation.journalTRANSPLANTATION PROCEEDINGS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume44
dc.identifier.issue6
dc.identifier.startpage1679
dc.identifier.endpage1684
dc.contributor.firstauthorID99606


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster